Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults

Frontiers in Bioscience

Volumn 13, Issue 5, 2008, Pages 1605-1609

  Rizza, Stacey A ^a   Tangalos, Eric G ^a   McClees, Mark D ^a   Strausbauch, Michael A ^b   Targonski, Paul V ^a   McKean, David J ^b   Wettstein, Peter J ^b   Badley, Andrew D ^a  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Age; HIV protease inhibitors; Nelfinavir; TREC

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

NELFINAVIR; PROTEINASE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; DRUG EFFECT; HUMAN; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; SERODIAGNOSIS; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HIV PROTEASE INHIBITORS; HIV SERONEGATIVITY; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; NELFINAVIR; T-LYMPHOCYTES;

EID: 38449106491     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2784     Document Type: Article

References (28)